Update on Ecstasy
Susanne A. Fogger
Journal of Psychosocial Nursing and Mental Health Services April 1, 2011 DOI: 10.3928/02793695-20110302-03 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Review Peer reviewed |
|---|---|
| Topics | MDMA |
| Citations | 2 |
| Key findings | Argues that ecstasy poses significant risks contrary to user perceptions of safety, and proposes that honest discussion emphasizing risk-reduction behaviors is needed to address increasing youth consumption. |
Abstract
After years of declining use in the United States, youth consumption of ecstasy has increased significantly. Although ecstasy (3, 4-methylenedioxymethamphetamine) is known to be a drug with detrimental effects, users view the drug as a safe and attractive social lubricant. To update and clarify misperceptions, this article reviews current evidence regarding ecstasy's side effects and risks and encourages honest discussion focusing on risk-reduction behaviors.
Comparable studies
Other narrative reviews on MDMA, most cited first.
| Study | Year | Design | Participants |
|---|---|---|---|
| Human Pharmacology of MDMA | 2004 | Review | |
| Human psychopharmacology of Ecstasy (MDMA): a review of 15 years of empirical research | 2001 | Review | |
| 3,4‐Methylenedioxymethamphetamine (MDMA, “Ecstasy”): pharmacology and toxicology in animals and humans | 1994 | Review | |
| (±)3,4-Methylenedioxymethamphetamine (‘Ecstasy’)-Induced Serotonin Neurotoxicity: Studies in Animals | 2000 | Review | |
| Amphetamine toxicities | 2010 | Review |
Citations in the library
Cites 8
- Neurotoxicity of methylenedioxyamphetamines (MDMA; ecstasy) in humans: how strong is the evidence for persistent brain damage? Addiction February 27, 2006
- Ecstasy (MDMA) dependence Drug and Alcohol Dependence January 7, 1999
- The psychotherapeutic potential of MDMA (3,4-methylenedioxymethamphetamine): an evidence-based review. Psychopharmacology April 1, 2007
- Rediscovering MDMA (ecstasy): the role of the American chemist Alexander T. Shulgin Addiction August 1, 2010
- Methylenedioxymethamphetamine (‘Ecstasy’)‐induced immunosuppression: a cause for concern? British Journal of Pharmacology May 27, 2010
and 3 more in the library